ArticleBMJ open2024

Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer.

Pierre Nahon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.